Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes

Osteoporosis International

Volumn 23, Issue 6, 2012, Pages 1799-1806

  Thrailkill, K M ^a,b   Jo, C H ^a,c   Cockrell, G E ^a   Moreau, C S ^a   Lumpkin Jr, C K ^a   Fowlkes, J L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Adiponectin; IGF 1; Insulin; Leptin; Osteoporosis

Indexed keywords

ADIPONECTIN; C PEPTIDE; CALCIUM; COLLAGEN TYPE 1; GAMMA CARBOXYGLUTAMIC CARBOXYLATED TYPE OSTEOCALCIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LEPTIN; OSTEOCALCIN; PARATHYROID HORMONE; SOMATOMEDIN C; TYPE 1 COLLAGEN DEGRADATION FRAGMENT; UNCLASSIFIED DRUG; UNDERCARBOXYLATED OSTEOCALCIN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADIPONECTIN; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-PEPTIDE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN; LEPTIN; MALE; OSTEOCALCIN; YOUNG ADULT;

EID: 84862751440     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-011-1807-7     Document Type: Article

References (34)

1. CraigME, Hattersley A, Donaghue K (2006) ISPAD Clinical Practice Consensus Guidelines 2006-2007. Definition, epidemiology and classification. Pediatr Diabetes 7:343-351.
2. Thrailkill KM (2000) Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol Ther 2:69-80. (Pubitemid 30256425)
3. Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL (2005) Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 289: E735-E745. (Pubitemid 41504371)
4. Nyman JS, Even JL, Jo CH, Herbert EG, Murry MR, Cockrell GE, Wahl EC, Bunn RC, Lumpkin CK Jr, Fowlkes JL, Thrailkill KM (2011) Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone. Bone 48:733-740.
5. Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Fowlkes JL (2011) Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab 96:142-149.
6. Hauschka PV, Lian JB, Cole DE, Gundberg CM (1989) Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69:990-1047. (Pubitemid 19184853)
7. Lian JB, Gundberg CM (1988) Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Relat Res (226):267-291. (Pubitemid 18049809)
8. Motyl KJ, McCabe LR, Schwartz AV (2010) Bone and glucose metabolism: a two-way street. Arch Biochem Biophys 503:2-10.
9. Szulc P, Delmas PD (2008) Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int 19:1683-1704.
10. Heuck C, Skjaerbaek C, Wolthers OD (1998) Diurnal rhythm of serum osteocalcin in normal children. Acta Paediatr 87:930-932. (Pubitemid 28439905)
11. Sokoll LJ, Booth SL, Davidson KW, Dallal GE, Sadowski JA (1998) Diurnal variation in total and undercarboxylated osteocalcin: influence of increased dietary phylloquinone. Calcif Tissue Int 62:447-452. (Pubitemid 28180842)
12. Ferron M, Hinoi E, Karsenty G, Ducy P (2008) Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105:5266-5270. (Pubitemid 351738545)
13. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-469. (Pubitemid 47208519)
14. Hwang YC, Jeong IK, Ahn KJ, Chung HY (2009) The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev 25:768-772.
15. Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, Sugimoto T (2011) Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 22:187-194.
16. Thrailkill KM, Bunn RC, Moreau CS, Cockrell GE, Simpson PM, Coleman HN, Frindik JP, Kemp SF, Fowlkes JL (2007) Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care 30:2321-2326. (Pubitemid 47359041)
17. Iki M, Tamaki J, Fujita Y, Kouda K, Yura A, Kadowaki E, Sato Y, Moon JS, Tomioka K, Okamoto N, Kurumatani N (2011) Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos Int (in press).
18. Maggio AB, Ferrari S, Kraenzlin M, Marchand LM, Schwitzgebel V, Beghetti M, Rizzoli R, Farpour-Lambert NJ (2010) Decreased bone turnover in children and adolescents with well controlled type 1 diabetes. J Pediatr Endocrinol Metab 23:697-707.
19. Pater A, Sypniewska G, Pilecki O (2010) Biochemical markers of bone cell activity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 23:81-86.
20. Nimptsch K, Hailer S, Rohrmann S, Gedrich K, Wolfram G, Linseisen J (2007) Determinants and correlates of serum undercarboxylated osteocalcin. Ann Nutr Metab 51:563-570. (Pubitemid 351315923)
21. Thrailkill KM, Fowlkes JL, Hyde JF, Litton JC (2001) The effects of co-therapy with recombinant human insulin-like growth factor I and insulin on serum leptin levels in adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2:25-29. (Pubitemid 32390317)
22. Imagawa A, Funahashi T, Nakamura T, Moriwaki M, Tanaka S, Nishizawa H, Sayama K, Uno S, Iwahashi H, Yamagata K, Miyagawa J, Matsuzawa Y (2002) Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 25:1665-1666.
23. Considine RV (2001) Regulation of leptin production. Rev Endocr Metab Disord 2:357-363. (Pubitemid 33640584)
24. Brophy S, Davies H, Stephens JW, Prior SL, Atkinson M, Bain S, Williams R (2010) Adiponectin levels in people with latent autoimmune diabetes-a case control study. BMC Res Notes 3:317.
25. Morales A, Wasserfall C, Brusko T, Carter C, Schatz D, Silverstein J, Ellis T, Atkinson M (2004) Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care 27:2010-2014. (Pubitemid 38989247)
26. Maahs DM, Hamman RF, D'Agostino R Jr, Dolan LM, Imperatore G, Lawrence JM, Marcovina SM, Mayer-Davis EJ, Pihoker C, Dabelea D (2009) The association between adiponectin/leptin ratio and diabetes type: the SEARCH for Diabetes in Youth Study. J Pediatr 155:133-135, 135 e131.
27. Leth H, Andersen KK, Frystyk J, Tarnow L, Rossing P, Parving HH, Flyvbjerg A (2008) Elevated levels of high-molecularweight adiponectin in type 1 diabetes. J Clin Endocrinol Metab 93:3186-3191.
28. Lee NK, Karsenty G (2008) Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 19:161-166. (Pubitemid 351847838)
29. Prats-Puig A, Mas-Parareda M, Riera-Perez E, Gonzalez-Forcadell D, Mier C, Mallol-Guisset M, Diaz M, Bassols J, de Zegher F, Ibanez L, Lopez-Bermejo A (2010) Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children. Diabetes Care 33:661-663.
30. Yang S, Xu H, Yu S, Cao H, Fan J, Ge C, Fransceschi RT, Dong HH, Xiao G (2011) Foxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblasts. J Biol Chem 286:19149-19158.
31. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G (2010) Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142:296-308.
32. Clemens TL, Karsenty G (2011) The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res 26:677-680.
33. Alexopoulou O, Jamart J, Devogelaer JP, Brichard S, de Nayer P, Buysschaert M (2006) Bone density and markers of bone remodeling in type 1 male diabetic patients. Diabetes Metab 32:453-458. (Pubitemid 44836587)
34. Liese AD, D'Agostino RB Jr, Hamman RF, Kilgo PD, Lawrence JM, Liu LL, Loots B, Linder B, Marcovina S, Rodriguez B, Standiford D, Williams DE (2006) The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 118:1510-1518 (Pubitemid 46393797)